Outcome | ||
---|---|---|
No Inactive Disease (n = 50/92; 54.3%) OR (95% CI) | ≥2 Episodes of Inactive Disease (n = 14/88; 15.9%) OR (95% CI) | |
Cyclosporine therapy (yes/no) | 3.97 (1.57–10.06)** | 0.13 (0.03–0.65)** |
Duration of methotrexate therapy (>4/≤ 4 yrs) | 2.67 (1.08–6.62)* | |
Swollen joint count at baseline (> 4/≤ 4) | 5.99 (1.45–24.77)** | |
Area under ROC curve of the model | 0.72 | 0.77 |